Cargando…
Current Perspectives of convalescent plasma therapy in COVID-19
The outbreak of the coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge to the health care communities across the globe. As of December 2020, a total of 69,874,432 confirmed COVID-19 cases with 1,553,000 deaths have been reported. Different regions of the world have reported var...
Autores principales: | Sahu, Kamal Kant, Mishra, Ajay Kumar, Raturi, Manish, Lal, Amos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927533/ https://www.ncbi.nlm.nih.gov/pubmed/33525227 http://dx.doi.org/10.23750/abm.v91i4.10681 |
Ejemplares similares
-
Review of clinical profile, risk factors, and outcomein patients with Tuberculosis and COVID -19
por: Mishra, Ajay Kumar, et al.
Publicado: (2021) -
An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19)
por: Mishra, Ajay Kumar, et al.
Publicado: (2020) -
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
por: Raturi, Manish, et al.
Publicado: (2021) -
Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India
por: Bansal, Naveen, et al.
Publicado: (2021) -
CT chest findings in coronavirus disease-19 (COVID-19)
por: Lal, Amos, et al.
Publicado: (2020)